1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
In an Investor Day presentation furnished under Form 8-K, Salesforce reiterated its FY27 revenue guidance at the high end of $46.1 billion to $46.4 billion and set a FY30 revenue target of $63 billion-plus. The company also disclosed a $25 billion accelerated share repurchase, which it expects to reduce its share count by at least 14%, a step that matters to shareholders because it returns capital and lifts per-share metrics.
FY27 revenue guidance is the high end of $46.1 billion to $46.4 billion, as of August 2026.
FY27 non-GAAP operating margin guidance is 34.3%, compared with 34.1% in FY26.
The $25 billion accelerated share repurchase is described as the company's largest ever, with an expected average share price of $182.
The FY30 revenue target of $63 billion-plus was stated as of May 2026 and includes Informatica.
AH Realty Trust filed its Q2 2026 investor presentation, which CEO Shawn Tibbetts and CFO Matthew Barnes-Smith will use in investor meetings starting September 16, 2026. The deck gives a revised 2026 outlook with higher same-store NOI growth ranges and reports leverage down to 7.1x after the $485 million multifamily portfolio sale. For shareholders, the filing shows lower debt and a larger buyback authorization, though it does not compare the quarter with prior-year results.
Revised 2026 FFO, As Adjusted per diluted share outlook of $0.53 to $0.57, or $52.3 million to $56.3 million in total FFO, As Adjusted.
Raised 2026 same-store cash NOI growth ranges: retail 2.50% to 3.50% and office 2.75% to 3.75%.
Net debt to total adjusted EBITDAre fell to 7.1x in 2Q26 from about 8.3x in 1Q26; target range is 5.5x to 6.5x.
Share repurchase authorization increased to $100 million; about 5.6 million shares repurchased for $33.2 million through June 30, 2026.
CalciMedica received a Nasdaq letter on September 15, 2026 confirming it has regained compliance with the minimum bid price rule, after its closing bid stayed at $1.00 or greater for 10 consecutive business days from August 31 to September 14, 2026. The company has no outstanding Nasdaq deficiency notices, which removes the risk of delisting over the bid price issue for shareholders.
Nasdaq notice of non-compliance dated March 16, 2026, after the bid price was below $1.00 for 30 consecutive business days
Compliance deadline was September 14, 2026, 180 calendar days after the notice
Nasdaq letter received September 15, 2026 confirmed compliance with Listing Rule 5550(a)(2)
Company reports no outstanding Nasdaq deficiency notices as of the filing date
Oscar Health said it will raise its full year 2026 guidance for earnings from operations to $600 million to $800 million, up $100 million from its prior expectation, and narrow its medical loss ratio outlook to 81.0% to 82.0%. It will reaffirm total revenue guidance of $18.7 billion to $19.0 billion and its SG&A expense ratio range of 15.6% to 16.1%, and will discuss strategy and long-term financial targets at its Investor Day on September 16, 2026.
Earnings from operations guidance raised to $600 million to $800 million, from $500 million to $700 million.
Medical loss ratio guidance improved to 81.0% to 82.0%, from a prior 81.5% to 82.5%.
Total revenue ($18.7 billion to $19.0 billion) and SG&A expense ratio (15.6% to 16.1%) guidance reaffirmed; Investor Day webcast held September 16, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.